Patent ID: 11963942
Assignee: HEALTH HOPE PHARMA LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 6:
7. A method of increasing at least one of taxane oral bioavailability, peak plasma concentration, and area under the curve for a taxane in an orally administered pharmaceutical composition comprising a taxane solution, wherein the taxane solution consists of the taxane in combination with a surfactant mixture consisting of a first surfactant that is polysorbate 80 and a second surfactant that is propane-1,2,3-triol-oxirane, wherein the ratio of the first surfactant to the second surfactant in the pharmaceutical composition is from 65:35 to 80:20 by weight, wherein the first surfactant and the second surfactant comprise at least 90% of the pharmaceutical composition by weight, and wherein the pharmaceutical composition is effective to form a micellar suspension.